4.7EUR
55.60 MEUR
529.30 MEUR
3.85 M
About VETOQUINOL
Sector
CEO
Matthieu Jean Frechin
Headquarters
Lure
Website
Employees (FY)
2.48 K
Founded
1962
ISIN
FR0004186856
FIGI
BBG00JHW0FX9
Vétoquinol SA operates as a global animal health company. It supplies drugs and nonmedicinal products for the livestock (cattle and pigs) and pet (dogs and cats) markets. The firm designs, develops and sells veterinary drugs and non-medicinal products in Europe, the Americas and the Asia Pacific region. It also manufactures antibiotic, anti-inflammatory, cardiology, and nephrology drugs. The company was founded by Joseph Frechin in 1933 and is headquartered in Lure, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0O1O is 98.8 EUR — it has decreased by 0.45% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange VETOQUINOL EUR2.5 stocks are traded under the ticker 0O1O.
0O1O stock is 2.00% volatile and has beta coefficient of 0.63. Check out the list of the most volatile stocks — is VETOQUINOL EUR2.5 there?
VETOQUINOL EUR2.5 revenue for the last quarter amounts to 134.00 M EUR despite the estimated figure of 134.00 M EUR. In the next quarter revenue is expected to reach 271.00 M EUR.
Yes, you can track VETOQUINOL EUR2.5 financials in yearly and quarterly reports right on TradingView.
0O1O stock has risen by 2.80% compared to the previous week, the month change is a 0.71% rise, over the last year VETOQUINOL EUR2.5 has showed a 15.02% increase.
0O1O net income for the last quarter is 23.37 M EUR, while the quarter before that showed 32.23 M EUR of net income which accounts for −27.48% change. Track more VETOQUINOL EUR2.5 financial stats to get the full picture.
Today VETOQUINOL EUR2.5 has the market capitalization of 1.16 B, it has increased by 1.14% over the last week.
Yes, 0O1O dividends are paid annually. The last dividend per share was 0.80 EUR. As of today, Dividend Yield (TTM)% is 0.82%. Tracking VETOQUINOL EUR2.5 dividends might help you take more informed decisions.
VETOQUINOL EUR2.5 dividend yield was 0.83% in 2023, and payout ratio reached 18.16%. The year before the numbers were 0.91% and 19.72% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 0O1O shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VETOQUINOL EUR2.5 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 2.48 K employees. See our rating of the largest employees — is VETOQUINOL EUR2.5 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VETOQUINOL EUR2.5 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VETOQUINOL EUR2.5 stock shows the buy signal. See more of VETOQUINOL EUR2.5 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on VETOQUINOL EUR2.5 future price: according to them, 0O1O price has a max estimate of 120.00 EUR and a min estimate of 97.00 EUR. Read a more detailed VETOQUINOL EUR2.5 forecast: see what analysts think of VETOQUINOL EUR2.5 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VETOQUINOL EUR2.5 EBITDA is 323.99 M EUR, and current EBITDA margin is 14.45%. See more stats in VETOQUINOL EUR2.5 financial statements.